Loading...
Docoh

Bruce Fund

Filed: 23 Aug 18, 8:00pm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act File number: 811-01528

 

Bruce Fund, Inc.

(Exact name of registrant as specified in charter)

 

 

 

20 North Wacker Drive, Suite 2414, Chicago, IL 60606

(Address of principal executive offices) (Zip code)

 

 

 

Robert B. Bruce

20 North Wacker Drive, Suite 2414

Chicago, Illinois 60606

(Name and address of agent for service)

 

Registrant's telephone number, including area code: 312-236-9160

 

Date of fiscal year end: June 30

 

Date of reporting period: 07/01/2017-06/30/2018

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (Secs. 239.24 and 274.5 of this chapter),to file reports with the Commission, not later than August 31 of each year, containing the registrant's proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b 1-4).The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

 

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget C'OMB") control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. Sec. 3507.

 

 

Bruce Fund        
Proxy Voting Record       
July 1, 2017 - June 30, 2018       

 

Security
Name
TickerCusipMeeting
Date
Proposed
(M) or (S)
DescriptionDid the
Fund Vote?
For, Against
or Abstain
For or Against
Management
EDAPEDAP2683111076/29/2018MAuditorsYesForFor
EDAPEDAP2683111076/29/2018MFinancialsYesForFor
EDAPEDAP2683111076/29/2018MAllocation net lossYesForFor
EDAPEDAP2683111076/29/2018MDirectorsYesForFor
         
AstrotechASTC04648410112/7/2017MDirectorsYesForFor
AstrotechASTC04648410112/7/2017MAuditorsYesForFor
AstrotechASTC04648410112/7/2017MReincorporationYesForFor
AstrotechASTC04648410112/7/2017MIncentive PlanYesForFor
         
CalpineCPN13134730412/15/2017MMergerYesForFor
CalpineCPN13134730412/15/2017MAdjournmentYesForFor
CalpineCPN13134730412/15/2017MCompensationYesForFor
         
GoldcorpGG3809564094/25/2018MDirectorsYesForFor
GoldcorpGG3809564094/25/2018MAuditorsYesForFor
GoldcorpGG3809564094/25/2018MCompensationYesForFor
         
Actua Corp.ACTA00509410712/7/2017MSaleYesForFor
Actua Corp.ACTA00509410712/7/2017MCompensationYesForFor
Actua Corp.ACTA00509410712/7/2017MAdjournmentYesForFor
         
Actua Corp.ACTA0050941074/18/2018MDissolutionYesForFor
Actua Corp.ACTA0050941074/18/2018MAdjournmentYesForFor
         
BungeBGG169621055/24/2018MDirectorsYesForFor
BungeBGG169621055/24/2018MAccountingYesForFor
BungeBGG169621055/24/2018MExecutive CompensationYesForFor
         
InsteelIIIN45774W1082/13/2018MDirectorsYesForFor
InsteelIIIN45774W1082/13/2018MAccountingYesForFor
InsteelIIIN45774W1082/13/2018MExecutive CompensationYesForFor
         
MerckMRK58933Y1055/22/2018MDirectorsYesForFor
MerckMRK58933Y1055/22/2018MAccountingYesForFor
MerckMRK58933Y1055/22/2018MCompensationYesForFor
MerckMRK58933Y1055/22/2018SWritten ConsentYesAgainstFor
         
IBMIBM4592001014/24/2018MDirectorsYesForFor
IBMIBM4592001014/24/2018MAccountingYesForFor
IBMIBM4592001014/24/2018MExecutive CompensationYesForFor
IBMIBM4592001014/24/2018SLobbyingYesForAgainst
IBMIBM4592001014/24/2018SSpecial MeetingsYesAgainstFor
IBMIBM4592001014/24/2018SIndependent ChairmanYesAgainstFor
         
PfizerPFE7170811034/26/2018MDirectorsYesForFor
PfizerPFE7170811034/26/2018MAccountingYesForFor
PfizerPFE7170811034/26/2018MExecutive CompensationYesForFor
PfizerPFE7170811034/26/2018MFrench Stock PlanYesForFor
PfizerPFE7170811034/26/2018SWritten ConsentYesAgainstFor
PfizerPFE7170811034/26/2018SLobbyingYesForAgainst
PfizerPFE7170811034/26/2018SIndependent ChairYesAgainstFor
         
NexteraNEE65339F1015/24/2018MDirectorsYesForFor
NexteraNEE65339F1015/24/2018MAuditorsYesForFor
NexteraNEE65339F1015/24/2018SWritten ConsentYesAgainstFor
NexteraNEE65339F1015/24/2018MCompensationYesForFor
NexteraNEE65339F1015/24/2018SPolitical ContributionsYesForAgainst
         
AllstateALL0200021015/11/2018MDirectorsYesForFor
AllstateALL0200021015/11/2018MAuditorsYesForFor
AllstateALL0200021015/11/2018MCompensationYesForFor
AllstateALL0200021015/11/2018SIndependent chairmanYesAgainstFor
AllstateALL0200021015/11/2018SPolitical ContributionsYesForAgainst
         
AllerganAGNG0177J1085/4/2017MDirectorsYesForFor
AllerganAGNG0177J1085/4/2017MCompensationYesForFor
AllerganAGNG0177J1085/4/2017MCompensation FrequencyYesForFor
AllerganAGNG0177J1085/4/2017MAccountingYesForFor
AllerganAGNG0177J1085/4/2017MIncentive CompensationYesForFor
AllerganAGNG0177J1085/4/2017SIndependent ChairmanYesAgainstFor
         
ValeantVRX91911K1024/30/2018MDirectorsYesForFor
ValeantVRX91911K1024/30/2018MCompensationYesForFor
ValeantVRX91911K1024/30/2018MSharesYesForFor
ValeantVRX91911K1024/30/2018MAuditorsYesForFor
         
SynergySYGP8716393086/12/2018MDirectorsYesForFor
SynergySYGP8716393086/12/2018MCompensationYesForFor
SynergySYGP8716393086/12/2018MCompensation FrequencyYesForFor
SynergySYGP8716393086/12/2018MAccountingYesForFor
SynergySYGP8716393086/12/2018MSharesYesForFor
SynergySYGP8716393086/12/2018MIncentive PlanYesForFor
         
FlotekFTK3433891024/27/2018MDirectorsYesForFor
FlotekFTK3433891024/27/2018MAuditorsYesForFor
FlotekFTK3433891024/27/2018MCompensationYesForFor
FlotekFTK3433891024/27/2018MLong-Term IncentiveYesForFor
         
AmercoUHAL0235861008/24/2017MDirectorsYesForFor
AmercoUHAL0235861008/24/2017MCompensationYesForFor
AmercoUHAL0235861008/24/2017MFrequencyYesForFor
AmercoUHAL0235861008/24/2017MAccountingYesForFor
         
AshlandASH441861041/25/2018MDirectorsYesForFor
AshlandASH441861041/25/2018MAuditorsYesForFor
AshlandASH441861041/25/2018MCompensationYesForFor
AshlandASH441861041/25/2018MIncentive CompensationYesForFor
         
ProthenaPRTAG728001085/15/2018MDirectorsYesForFor
ProthenaPRTAG728001085/15/2018MAuditorsYesForFor
ProthenaPRTAG728001085/15/2018MCompensationYesForFor
ProthenaPRTAG728001085/15/2018MLong term Incentive PlanYesForFor
         
AbbottABT0028241004/27/2018MDirectorsYesForFor
AbbottABT0028241004/27/2018MSay on PayYesForFor
AbbottABT0028241004/27/2018MAccountingYesForFor
AbbottABT0028241004/27/2018SIndependent ChairmanYesAgainstFor
         
Sirius XM HoldingSIRI82968B1036/5/2018MDirectorsYesForFor
Sirius XM HoldingSIRI82968B1036/5/2018MAccountingYesForFor
         
Duke EnergyDUK26441C2045/3/2018MDirectorsYesForFor
Duke EnergyDUK26441C2045/3/2018MAuditorsYesForFor
Duke EnergyDUK26441C2045/3/2018MCompensationYesForFor
Duke EnergyDUK26441C2045/3/2018MVotingYesForFor
Duke EnergyDUK26441C2045/3/2018SLobbying ExpensesYesForAgainst
         
AvistaAVA05379B10711/21/2017MMergerYesForFor
AvistaAVA05379B10711/21/2017MAdjourmentYesForFor
AvistaAVA05379B10711/21/2017MCompensationYesForFor
         
SolitarioXPL8342EP1076/19/2018MDirectorsYesForFor
SolitarioXPL8342EP1076/19/2018MAuditorsYesForFor
SolitarioXPL8342EP1076/19/2018MCompensationYesForFor
SolitarioXPL8342EP1076/19/2018M Incentive PlanYesForFor
SolitarioXPL8342EP1076/19/2018MCompensation FrequencyYesForFor
         
XCEL EnergyXEL98389B1005/16/2018MDirectorsYesForFor
XCEL EnergyXEL98389B1005/16/2018MAuditorsYesForFor
XCEL EnergyXEL98389B1005/16/2018MCompensationYesForFor
         
PetroquestPQ7167481085/16/2018MDirectorsYesForFor
PetroquestPQ7167481085/16/2018MAuditorsYesForFor
PetroquestPQ7167481085/16/2018MCompensationYesForFor
PetroquestPQ7167481085/16/2018MLong-Term IncentiveYesForFor
         
PetroquestPQ71674810811/29/2017MStock SplitYesForFor
PetroquestPQ71674810811/29/2017MAmendmentYesForFor
PetroquestPQ71674810811/29/2017MSpecial MeetingYesForFor
         
         
General MotorsGM37045V1006/12/2018MDirectorsYesForFor
General MotorsGM37045V1006/12/2018MAuditorsYesForFor
General MotorsGM37045V1006/12/2018MCompensationYesForFor
General MotorsGM37045V1006/12/2018SEmissionsYesAgainstFor
General MotorsGM37045V1006/12/2018SIndependent ChairmanYesAgainstFor
General MotorsGM37045V1006/12/2018SWritten ConsentYesAgainstFor
         
ValvolineVVV92047W1011/31/2018MDirectorsYesForFor
ValvolineVVV92047W1011/31/2018MAuditorsYesForFor
ValvolineVVV92047W1011/31/2018MCompensationYesForFor
ValvolineVVV92047W1011/31/2018MStock PlanYesForFor

 

 

SIGNATURES

 

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Bruce Fund, Inc.

 

By: /s/ Robert B. Bruce 
 Robert B. Bruce, President 
   
Date:8-24-18